AI Economy Reshapes American Dream BlueCollar Workers Emerge as Winners Amid WhiteCollar Slowdown Chinas AI Push Balancing Innovation with Employment Stability Blue Origin Invests 600 Million to Expand Florida Campus Boosting Space Coast Operations UK Capital Gains Tax Alignment Proposal Sparks Debate Among Investors Health Ministry Tightens Pregabalin Regulations Under Schedule H1 to Curb Misuse Goldman Sachs Exits Apple Card Partnership Stock Enters Potential Buy Zone GBCI Q1 2026 Earnings EPS Misses Expectations Amid Challenging Operating Environment Worthington Enterprises Inc WOR Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Operations VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Beat Heidmar Maritime Holdings Corp HMR Q1 2026 Earnings Massive EPS Beat of 1076 Surprise MSEX Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Edges Higher GREE Q1 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Discontinuation Mineralys Therapeutics MLYS Edges Lower as Tight Trading Range Persists Marsh MRSH Experiences Slight Decline Amidst Steady Trading comScore SCOR Slides 25 as Stock Tests Key Support Levels Fold Holdings FLD Nears Key Support at 094 as Shares Slide 168 Saratoga Investment Corp SAR Holds Steady at 2223 Amid Tight Trading Range Qualcomm Stock Surge Reflects Growing Market Optimism for AI Device Expansion FFWM Q4 2025 Earnings Significant EPS Miss Amidst Challenging Environment BioRad Laboratories BIO Surges 44 as Bullish Momentum Builds From Key Support Level Loews Corporation Q1 2026 Earnings Solid EPS Amid Mixed Segment Performance Monroe Capital Corporation Q4 2025 Earnings EPS Surpasses Estimates by Nearly 20 CETX Q3 2024 Earnings Deep EPS Miss Raises Concerns Amid Operational Challenges DDL Q4 2025 Earnings Positive EPS Reported Amid Mixed Market Reaction Opendoor Technologies OPEN Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Improvement BOBS Q1 2026 Earnings EPS Surges Past Estimates Shares Dip Despite Strong Beat IVVD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress